Laxative Effectiveness of a Phytotherapeutic Tea
Primary Purpose
Chronic Constipation
Status
Completed
Phase
Phase 2
Locations
Brazil
Study Type
Interventional
Intervention
Placebo
Klein Laxative Tea
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Constipation focused on measuring constipation, RCT, phytotherapy
Eligibility Criteria
Inclusion criteria:
- patients with 18 to 55 years old with chronic constipation according to the criteria of the American Association of Gastroenterology (AAG);
- patients should present good understanding and collaboration capacity, an not be in use of other medications with effects on the intestinal habit;
- patients with no abnormalities in the exams;
- willing to sign a written informed consent;
- women in fertile age should make use of appropriate anti-conception.
Exclusion Criteria:
- pregnant or breast feeding women;
- patients with history of abuse of alcohol or use of drugs;
- significant or not-controlled disease, except constipation.
Sites / Locations
- Hospital de Clínicas de Porto Alegre
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Placebo/Laxative tea crossover
Laxative tea/Placebo crossover
Arm Description
This arm received placebo in the first period and laxative tea in the second period (after washout period of 9 days).
This arm received laxative tea in the first intervention period and placebo in the second intervention period (after washout period of 9 days).
Outcomes
Primary Outcome Measures
Intestinal Transit Time
Radiologic technique consisting of the ingestion of radiopaque markers, followed by a simple x-ray of the abdomen on day 3 of each intervention period. Standard formula, regarding markers ingested, time of ingestion and markers still present on the colon (counted by radiologist unaware of the treatment allocation), provided transit time.
Secondary Outcome Measures
Number of Patients With no Evacuation After Each Intervention Period
The number of patients who had not evacuated on day 5 of each intervention period was obtained using questions 1 and 9 of the Scale for Assessment of Constipation Symptoms based on: 1) How many times have you had a bowel movement in the last 24 hours?; 9) Classification of bowel habit on a scale of 1 (terrible) to 5 (excellent).
Full Information
NCT ID
NCT00872430
First Posted
November 6, 2008
Last Updated
June 16, 2009
Sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Federal University of Rio Grande do Sul, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Laboratório Klein Ltda.
1. Study Identification
Unique Protocol Identification Number
NCT00872430
Brief Title
Laxative Effectiveness of a Phytotherapeutic Tea
Official Title
Laxative Effectiveness of a Phytotherapeutic Tea: A Randomized Placebo-Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2009
Overall Recruitment Status
Completed
Study Start Date
July 2002 (undefined)
Primary Completion Date
December 2002 (Actual)
Study Completion Date
June 2003 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Federal University of Rio Grande do Sul, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Laboratório Klein Ltda.
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to evaluate the efficacy and safety of a phytotherapeutic laxative tea, composed by Pimpinella anisum, Foeniculum vulgare, Sambucus nigra and Cassia angustifolia, in a randomized crossover placebo-controlled clinical trial in patients with chronic constipation.
Detailed Description
The Klein Laxative Tea is a pharmaceutical phytotherapeutic product that's been used for several years in Brazil for the treatment of constipation. This product contains fruit of Pimpinella anisum (green anises), fruit of Foeniculum vulgare (fennel), flowers of Sambucus nigra (elder tree) and flowers of Cassia angustifolia (senna). In spite of the beneficial effects of its components, separately demonstrated in vitro, it never had its effectiveness appraised in a randomized clinical trial.The purpose of this study was to evaluate the efficacy and safety of this product in a randomized crossover placebo-controlled clinical trial. Twenty patients presenting with the criteria of the American Association of Gastroenterology for chronic constipation were included, and concluded a two-phase crossover study. The primary endpoint was the evaluation of the intestinal transit time measured through radiological technique. The secondary endpoints were the number of evacuations, subjective impression of the quality in the intestinal habit, quality of life appraised through WHOQOL-brief and adverse effects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Constipation
Keywords
constipation, RCT, phytotherapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Placebo/Laxative tea crossover
Arm Type
Active Comparator
Arm Description
This arm received placebo in the first period and laxative tea in the second period (after washout period of 9 days).
Arm Title
Laxative tea/Placebo crossover
Arm Type
Active Comparator
Arm Description
This arm received laxative tea in the first intervention period and placebo in the second intervention period (after washout period of 9 days).
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
In order to produce similar taste and color, 7 drops of caramel color and 10 drops of orange essence were mixed into 1.6 liters of boiling water. The patients received 150 ml of placebo 3 times a day for 5 days.
Intervention Type
Other
Intervention Name(s)
Klein Laxative Tea
Other Intervention Name(s)
Phytotherapeutic tea, laxative tea
Intervention Description
The laxative tea was prepared using 1 gram of grinded plant into 150 ml of water, left under infusion by 5 minutes. Patients received 150 ml of tea 3 times a day for 5 days.
Primary Outcome Measure Information:
Title
Intestinal Transit Time
Description
Radiologic technique consisting of the ingestion of radiopaque markers, followed by a simple x-ray of the abdomen on day 3 of each intervention period. Standard formula, regarding markers ingested, time of ingestion and markers still present on the colon (counted by radiologist unaware of the treatment allocation), provided transit time.
Time Frame
day 3 and day 17
Secondary Outcome Measure Information:
Title
Number of Patients With no Evacuation After Each Intervention Period
Description
The number of patients who had not evacuated on day 5 of each intervention period was obtained using questions 1 and 9 of the Scale for Assessment of Constipation Symptoms based on: 1) How many times have you had a bowel movement in the last 24 hours?; 9) Classification of bowel habit on a scale of 1 (terrible) to 5 (excellent).
Time Frame
day 5 and day 19
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
patients with 18 to 55 years old with chronic constipation according to the criteria of the American Association of Gastroenterology (AAG);
patients should present good understanding and collaboration capacity, an not be in use of other medications with effects on the intestinal habit;
patients with no abnormalities in the exams;
willing to sign a written informed consent;
women in fertile age should make use of appropriate anti-conception.
Exclusion Criteria:
pregnant or breast feeding women;
patients with history of abuse of alcohol or use of drugs;
significant or not-controlled disease, except constipation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paulo D picon, Coordinator
Organizational Affiliation
Hospital de Clínicas de Porto Alegre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital de Clínicas de Porto Alegre
City
Porto Alegre
State/Province
Rio Grande do Sul
ZIP/Postal Code
90035903
Country
Brazil
12. IPD Sharing Statement
Citations:
PubMed Identifier
20433751
Citation
Picon PD, Picon RV, Costa AF, Sander GB, Amaral KM, Aboy AL, Henriques AT. Randomized clinical trial of a phytotherapic compound containing Pimpinella anisum, Foeniculum vulgare, Sambucus nigra, and Cassia augustifolia for chronic constipation. BMC Complement Altern Med. 2010 Apr 30;10:17. doi: 10.1186/1472-6882-10-17.
Results Reference
derived
Learn more about this trial
Laxative Effectiveness of a Phytotherapeutic Tea
We'll reach out to this number within 24 hrs